StockVS

NASDAQ · Health Information Services · USD

Omada Health, Inc. (OMDA) Stock Analysis

Omada Health, Inc. (OMDA) is a Health Information Services stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

OMDA

$19.66

+$0.32 (+1.65%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare OMDA with… →

OMDA Key Statistics

As of Oct 21, 2026
Trading
Open
$19.44
Previous Close
$19.34
Day's Range
19.35–19.80
52-Week Range
10.28–26.92
Volume
1.30M
Valuation
Market Cap
$1.20B
P/E Ratio
81.92
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
35.35
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
3.89
EPS (ttm)Profit attributable to each share over the last twelve months.
0.24
Financials (FY)
Revenue (FY)
$260.21M+53.24%
Net Income (FY)
−$12.78M
Profit marginThe share of revenue left as profit after all costs and taxes.
1.39%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
61.22M
1-Year Return
−21.74%
Dividend and dates
Earnings Date
November 5, 2026
Avg Volume
1.41M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, OMDA closed at $19.66, −21.74% over 1 year.

Omada Health, Inc. (OMDA) has a market capitalization of $1.20B.

In fiscal 2025, OMDA reported revenue of $260.21M.

OMDA Stock Return by Calendar Year

Omada Health, Inc. (OMDA) return since Jun 2025: what $10,000 became

1 year
$10,000 $7,826
−21.74%
Since Jun 2025
$10,000 $8,548
−14.52%

If you had invested $10,000 in Omada Health, Inc. (OMDA) at the close on June 6, 2025, the earliest close on record here, it would have been worth $8,548 at the close on October 21, 2026: −14.52% in total, −10.79% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+24.59%
2025 (partial year)−31.39%

As of October 21, 2026.

OMDA Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$260.21M−$12.78M−4.9%
2024$169.80M−$47.14M−27.8%
2023$122.78M−$67.51M−55.0%
2022$89.19M−$72.52M−81.3%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$260.21M$170.94M−$11.97M−$12.78M−4.9%
2024$169.80M$102.88M−$43.65M−$47.14M−27.8%
2023$122.78M$69.97M−$66.00M−$67.51M−55.0%
2022$89.19M$42.79M−$72.35M−$72.52M−81.3%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

OMDA Valuation vs Health Information Services Median

Median of 44 stocks
MetricOMDAHealth Information Services medianvs median
P/E81.9246.5476% above
P/S ratio3.892.3168% above
Profit margin1.39%−7.55%8.9 pts above

Medians across 44 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Omada Health, Inc. (OMDA) is capitalised at $1.20B on the latest close. It is classified in the Health Information Services industry, within the Healthcare sector. The company reports 946 employees.

The 52-week range on file runs from $10.28 to $26.92. OMDA last closed at $19.66 on October 21, 2026. That is +$0.32 (+1.65%) against the previous close. The latest close sits 91.25% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $260.21M. Against the prior fiscal year total of $169.80M, that is a change of +53.24%. The same year closed with a net loss of $12.78M. The reported profit margin is 1.39%. That is 8.9 percentage points above the Health Information Services median of −7.55%. Trailing earnings per share are 0.24.

Across the 4 fiscal years on file, revenue moves from $89.19M in 2022 to $260.21M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

OMDA trades at a trailing price-to-earnings ratio of 81.92. That is 76.02% above the Health Information Services median of 46.54. On forward earnings the ratio is 35.35. Measured against sales, the shares trade at 3.89 times revenue. On price-to-sales that is 68.47% above the Health Information Services median of 2.31. 44 Health Information Services companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the total return is −21.74%. Annualized volatility over the trailing 1 year is 62.74%.

Growth & Income

No dividend is on file for OMDA.

2026 is still running; the total return is +24.59% year to date.

Peer Comparison

Omada Health, Inc. (OMDA) operates in the Health Information Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Omada Health, Inc. OMDA $1.20B 81.9
Veeva Systems Inc. VEEV $51.90B 52.6
BrightSpring Health Services, Inc. BTSG $12.40B 55.4
Tempus AI, Inc. TEM $12.23B —

The Health Information Services industry average P/E ratio is 46.5x. Omada Health, Inc. trades at a P/E of 81.9.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Health Information Services Stocks

View all Health Information Services stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About Omada Health, Inc.

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.

Visit website →